Axsome Therapeutics Inc.
AXSM | NASDAQ
$136.01
-$8.42 (-5.83%)
At close: Nov 2, 2026, 4:00 PM ET
$137.00
-$7.43 (-5.14%)
Pre-market:
Nov 2, 2026, 9:28 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -49.63 | -14.13 | -15.10 | -16.77 | -10.89 | -28.79 |
PEG Ratio | 1.29 | -1.03 | -1.04 | -0.51 | -0.48 | -0.76 |
PS Ratio | 14.23 | 10.51 | 13.36 | 62.67 | n/a | n/a |
PB Ratio | 102.90 | 71.10 | 18.93 | 28.62 | 90.93 | 26.64 |
P/FCF Ratio | -96.78 | -31.50 | -24.82 | -26.75 | -13.09 | -38.61 |
P/OCF Ratio | -97.27 | -31.57 | -24.92 | -26.91 | -13.13 | -38.64 |
OCF/S Ratio | -14.63 | -33.29 | -53.61 | -232.85 | n/a | n/a |
Debt / Equity Ratio | 2.73 | 3.38 | 0.98 | 0.86 | 3.18 | 0.44 |
Quick Ratio | 1.48 | 2.04 | 3.52 | 2.50 | 3.75 | 7.85 |
Current Ratio | 1.55 | 2.11 | 3.63 | 2.54 | 3.75 | 7.85 |
Asset Turnover | 0.93 | 0.68 | 0.46 | 0.15 | n/a | n/a |
Interest Coverage | -25.81 | -42.71 | -35.93 | -24.51 | -21.89 | -38.64 |
Return on Equity | -207.46% | -503.76% | -125.27% | -170.81% | -834.29% | -90.43% |
Return on Assets | -26.55% | -50.52% | -40.67% | -56.45% | -148.55% | -55.28% |
Return on Invested Capital | -43.95% | -82.12% | -51.44% | -76.40% | -190.86% | -60.48% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 92.56% | 91.37% | 90.37% | 89.61% | n/a | n/a |
Net Profit Margin | -28.69% | -74.47% | -88.41% | -373.99% | n/a | n/a |
Pretax Profit Margin | -28.77% | -74.45% | -88.06% | -373.99% | n/a | n/a |
Operating Profit Margin | -26.51% | -72.74% | -85.67% | -359.33% | n/a | n/a |
FCF Margin | -14.70% | -33.36% | -53.83% | -234.25% | n/a | n/a |
EBITDA Margin | -26.32% | -70.68% | -83.15% | -350.53% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AXSM